Verastem reported $-32.92M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 695M 1.12B Mar/2026
Alaunos Therapeutics USD -1.01M 153K Mar/2026
AstraZeneca USD 3.08B 754M Mar/2026
Curis USD 19.36M 31.16M Dec/2025
Cytokinetics USD -206.03M 23M Mar/2026
Gilead Sciences USD 2.02B 162M Mar/2026
Incyte USD 303.33M 4.05M Mar/2026
Laboratory Of America USD 277.8M 113.1M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Pfizer USD 2.69B 4.34B Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
TG Therapeutics USD 19.78M 3.26M Mar/2026
Verastem USD -32.92M 24.66M Dec/2025